Atherosclerosis originating from childhood: Specific features

Anastasia V. Poznyak , Alexey A. Yakovlev , Mikhail А. Popov , Elena B. Zhigmitova , Vasily N. Sukhorukov , Alexander N. Orekhov

Journal of Biomedical Research ›› 2024, Vol. 38 ›› Issue (3) : 233 -240.

PDF (1881KB)
Journal of Biomedical Research ›› 2024, Vol. 38 ›› Issue (3) :233 -240. DOI: 10.7555/JBR.37.20230198
Review Article
research-article
Atherosclerosis originating from childhood: Specific features
Author information +
History +
PDF (1881KB)

Abstract

Atherosclerosis is extremely widespread. Traditionally, it is considered a disease of older people, who most often experience problems with the heart and blood vessels. While much attention from the scientific community has been paid to studying the association between aging and atherosclerosis, as well as its consequences, there is evidence that atherosclerosis occurs at an early age. Atherosclerosis may form both during intrauterine development and in childhood. Nutrition plays an important role in childhood atherosclerosis, along with previous infectious diseases and excess weight of both the child and the mother. In the present review, we examined the development of atherosclerosis and the prerequisites in childhood.

Keywords

atherosclerosis / childhood / pediatrics / cardiovascular disease

Cite this article

Download citation ▾
Anastasia V. Poznyak, Alexey A. Yakovlev, Mikhail А. Popov, Elena B. Zhigmitova, Vasily N. Sukhorukov, Alexander N. Orekhov. Atherosclerosis originating from childhood: Specific features. Journal of Biomedical Research, 2024, 38(3): 233-240 DOI:10.7555/JBR.37.20230198

登录浏览全文

4963

注册一个新账户 忘记密码

Fundings

This research was funded by the Russian Science Foundation (Grant No.23-45-00031).

Acknowledgments

None.

References

[1]

Libby P. The changing landscape of atherosclerosis[J]. Nature, 2021, 592(7855): 524-533. doi: 10.1038/s41586-021-03392-8

[2]

Hayman LL. Prevention of atherosclerotic cardiovascular disease in childhood[J]. Curr Cardiol Rep, 2020, 22(9): 86. doi: 10.1007/s11886-020-01332-y

[3]

Francula-Zaninovic S, Nola IA. Management of measurable variable cardiovascular disease' risk factors[J]. Curr Cardiol Rev, 2018, 14(3): 153-163. doi: 10.2174/1573403X14666180222102312

[4]

Joseph A, Ackerman D, Talley JD, et al. Manifestations of coronary atherosclerosis in young trauma victims-an autopsy study[J]. J Am Coll Cardiol, 1993, 22(2): 459-467. doi: 10.1016/0735-1097(93)90050-B

[5]

Hong YM. Atherosclerotic cardiovascular disease beginning in childhood[J]. Korean Circ J, 2010, 40(1): 1-9. doi: 10.4070/kcj.2010.40.1.1

[6]

Linton MF, Yancey PG, Davies SS, et al. The role of lipids and lipoproteins in atherosclerosis[M]//Feingold KR, Anawalt B, Blackman MR, et al. Endotext[Internet]. South Dartmouth: MDText. com, Inc., 2019.

[7]

Tanaka K, Masuda J, Imamura T, et al. A nation-wide study of atherosclerosis in infants, children and young adults in Japan[J]. Atherosclerosis, 1988, 72(2-3): 143-156. doi: 10.1016/0021-9150(88)90075-5

[8]

Imakita M, Yutani C, Strong JP, et al. Second nation-wide study of atherosclerosis in infants, children and young adults in Japan[J]. Atherosclerosis, 2001, 155(2): 487-497. doi: 10.1016/S0021-9150(00)00595-5

[9]

Cheung CL, Cheung BMY. Predictors of carotid atherosclerosis in young adults: insights from the Bogalusa Heart Study[J]. J Am Heart Assoc, 2021, 10(12): e021887. doi: 10.1161/JAHA.121.021887

[10]

Grootaert MOJ, Bennett MR. Vascular smooth muscle cells in atherosclerosis: time for a re-assessment[J]. Cardiovasc Res, 2021, 117(11): 2326-2339. doi: 10.1093/cvr/cvab046

[11]

Tsukinoki R, Okamura T, Watanabe M, et al. Blood pressure, low-density lipoprotein cholesterol, and incidences of coronary artery disease and ischemic stroke in Japanese: the Suita study[J]. Am J Hypertens, 2014, 27(11): 1362-1369. doi: 10.1093/ajh/hpu059

[12]

Genovesi S, Giussani M, Lieti G, et al. Evidence and uncertainties on lipoprotein(a) as a marker of cardiovascular health risk in children and adolescents[J]. Biomedicines, 2023, 11(6): 1661. doi: 10.3390/biomedicines11061661

[13]

Simeunovic A, Brunborg C, Heier M, et al. Sustained low-grade inflammation in young participants with childhood onset type 1 diabetes: The Norwegian atherosclerosis and childhood diabetes (ACD) study[J]. Atherosclerosis, 2023, 379: 117151. doi: 10.1016/j.atherosclerosis.2023.05.020

[14]

Asada Y, Yamashita A, Sato Y, et al. Pathophysiology of atherothrombosis: Mechanisms of thrombus formation on disrupted atherosclerotic plaques[J]. Pathol Int, 2020, 70(6): 309-322. doi: 10.1111/pin.12921

[15]

Levy D. Combating the epidemic of heart disease[J]. JAMA, 2012, 308(24): 2624-2625. doi: 10.1001/jama.2012.164971

[16]

Venkatesh K, Deepak DC, Venkatesha VT. Escalation of coronary atherosclerosis in younger people by comparison of two autopsy studies conducted a decade apart[J]. Heart Views, 2018, 19(4): 128-136. doi: 10.4103/HEARTVIEWS.HEARTVIEWS_49_17

[17]

Zhang Y, Guallar E, Qiao Y, et al. Is carotid intima-media thickness as predictive as other noninvasive techniques for the detection of coronary artery disease?[J]. Arterioscler Thromb Vasc Biol, 2014, 34(7): 1341-1345. doi: 10.1161/ATVBAHA.113.302075

[18]

Sobenin IA, Sazonova MA, Postnov AY, et al. Changes of mitochondria in atherosclerosis: possible determinant in the pathogenesis of the disease[J]. Atherosclerosis, 2013, 227(2): 283-288. doi: 10.1016/j.atherosclerosis.2013.01.006

[19]

Adam CA, Șalaru DL, Prisacariu C, et al. Novel biomarkers of atherosclerotic vascular disease-latest insights in the research field[J]. Int J Mol Sci, 2022, 23(9): 4998. doi: 10.3390/ijms23094998

[20]

Summerhill VI, Grechko AV, Yet SF, et al. The atherogenic role of circulating modified lipids in atherosclerosis[J]. Int J Mol Sci, 2019, 20(14): 3561. doi: 10.3390/ijms20143561

[21]

Orekhov AN, Bobryshev YV, Sobenin IA, et al. Modified low density lipoprotein and lipoprotein-containing circulating immune complexes as diagnostic and prognostic biomarkers of atherosclerosis and type 1 diabetes macrovascular disease[J]. Int J Mol Sci, 2014, 15(7): 12807-12841. doi: 10.3390/ijms150712807

[22]

Lee Y, Siddiqui WJ. Cholesterol levels[M]. Treasure Island (FL): StatPearls Publishing, 2023.

[23]

Tertov VV, Sobenin IA, Kaplun VV, et al. Antioxidant content in low density lipoprotein and lipoprotein oxidation in vivo and in vitro[J]. Free Radic Res, 1998, 29(2): 165-173. doi: 10.1080/10715769800300191A

[24]

Tanaka K, Tokumaru S, Kojo S. Possible involvement of radical reactions in desialylation of LDL[J]. FEBS Lett, 1997, 413(2): 202-204. doi: 10.1016/S0014-5793(97)00917-4

[25]

Yu L, Peng J, Mineo C. Lipoprotein sialylation in atherosclerosis: Lessons from mice[J]. Front Endocrinol (Lausanne), 2022, 13: 953165. doi: 10.3389/fendo.2022.953165

[26]

Poznyak AV, Sukhorukov VN, Surkova R, et al. Glycation of LDL: AGEs, impact on lipoprotein function, and involvement in atherosclerosis[J]. Front Cardiovasc Med, 2023, 10: 1094188. doi: 10.3389/fcvm.2023.1094188

[27]

Raitakari O, Kartiosuo N, Pahkala K, et al. Lipoprotein(a) in youth and prediction of major cardiovascular outcomes in adulthood[J]. Circulation, 2023, 147(1): 23-31. doi: 10.1161/CIRCULATIONAHA.122.060667

[28]

Swerdlow DI, Rider DA, Yavari A, et al. Treatment and prevention of lipoprotein(a)-mediated cardiovascular disease: the emerging potential of RNA interference therapeutics[J]. Cardiovasc Res, 2022, 118(5): 1218-1231. doi: 10.1093/cvr/cvab100

[29]

McNeal CJ, Peterson AL, Feingold KR, et al. Lipoprotein (a) in youth[M]// Feingold KR, Anawalt B, Blackman MR, et al. Endotext. South Dartmouth: MDText. com, Inc., 2023.

[30]

Higgins V, Adeli K. Postprandial dyslipidemia in insulin resistant states in adolescent populations[J]. J Biomed Res, 2020, 34(5): 328-342. doi: 10.7555/JBR.34.20190094

[31]

Milutinović A, Šuput D, Zorc-Pleskovič R. Pathogenesis of atherosclerosis in the tunica intima, media, and adventitia of coronary arteries: An updated review[J]. Bosn J Basic Med Sci, 2020, 20(1): 21-30. https://pubmed.ncbi.nlm.nih.gov/31465719/

[32]

Guerri-Guttenberg R, Castilla R, Cao G, et al. Coronary intimal thickening begins in fetuses and progresses in pediatric population and adolescents to atherosclerosis[J]. Angiology, 2020, 71(1): 62-69. doi: 10.1177/0003319719849784

[33]

Subbotin VM. Pattern of organ remodeling in chronic non-communicable diseases is due to endogenous regulations and falls under the category of Kauffman's self-organization: A case of arterial neointimal pathology[J]. Med Hypotheses, 2020, 143: 110106. doi: 10.1016/j.mehy.2020.110106

[34]

Allahverdian S, Chaabane C, Boukais K, et al. Smooth muscle cell fate and plasticity in atherosclerosis[J]. Cardiovasc Res, 2018, 114(4): 540-550. doi: 10.1093/cvr/cvy022

[35]

Mainieri F, La Bella S, Chiarelli F. Hyperlipidemia and cardiovascular risk in children and adolescents[J]. Biomedicines, 2023, 11(3): 809. doi: 10.3390/biomedicines11030809

[36]

Stary HC. Macrophages, macrophage foam cells, and eccentric intimal thickening in the coronary arteries of young children[J]. Atherosclerosis, 1987, 64(2-3): 91-108. doi: 10.1016/0021-9150(87)90234-6

[37]

Zhou M, Yu Y, Chen R, et al. Wall shear stress and its role in atherosclerosis[J]. Front Cardiovasc Med, 2023, 10: 1083547. doi: 10.3389/fcvm.2023.1083547

[38]

Mironov AA, Rekhter MD, Kolpakov VA, et al. Heterogeneity of smooth muscle cells in embryonic human aorta[J]. Tissue Cell, 1995, 27(1): 31-38. doi: 10.1016/S0040-8166(95)80006-9

[39]

Costa D, Andreucci M, Ielapi N, et al. Vascular biology of arterial aneurysms[J]. Ann Vasc Surg, 2023, 94: 378-389. doi: 10.1016/j.avsg.2023.04.008

[40]

Schwartz SM, Virmani R, Majesky MW. An update on clonality: what smooth muscle cell type makes up the atherosclerotic plaque?[J]. F1000Res, 2018, 7: F1000 Faculty Rev-1969. https://pubmed.ncbi.nlm.nih.gov/30613386/

[41]

Green ID, Liu R, Wong JJL. The expanding role of alternative splicing in vascular smooth muscle cell plasticity[J]. Int J Mol Sci, 2021, 22(19): 10213. doi: 10.3390/ijms221910213

[42]

Wang G, Jacquet L, Karamariti E, et al. Origin and differentiation of vascular smooth muscle cells[J]. J Physiol, 2015, 593(14): 3013-3030. doi: 10.1113/JP270033

[43]

Ontsouka E, Schroeder M, Albrecht C. Revisited role of the placenta in bile acid homeostasis[J]. Front Physiol, 2023, 14: 1213757. doi: 10.3389/fphys.2023.1213757

[44]

Özbiçer S, Yüksel G, Urgun ÖD. Triglyceride glucose index is independently associated with aortic intima-media thickness in patients without known atherosclerotic cardiovascular disease or diabetes[J]. Diab Vasc Dis Res, 2022, 19(5): 14791641221136203. doi: 10.1177/14791641221136203

[45]

Palinski W. Effect of maternal cardiovascular conditions and risk factors on offspring cardiovascular disease[J]. Circulation, 2014, 129(20): 2066-2077. doi: 10.1161/CIRCULATIONAHA.113.001805

[46]

Gerosa C, Faa G, Fanni D, et al. Fetal programming of atherosclerosis: may the barker hypothesis explain the susceptibility of a subset of patients to develop stroke or cardiac infarct?[J]. Eur Rev Med Pharmacol Sci, 2021, 25(21): 6633-6641. https://pubmed.ncbi.nlm.nih.gov/34787867/

[47]

Wilson DP. Is atherosclerosis a pediatric disease?[M]// Feingold KR, Anawalt B, Blackman MR, et al. Endotext[Internet]. South Dartmouth: MDText. com, Inc., 2020.

[48]

Chistiakov DA, Sobenin IA, Orekhov AN. Strategies to deliver microRNAs as potential therapeutics in the treatment of cardiovascular pathology[J]. Drug Deliv, 2012, 19(8): 392-405. doi: 10.3109/10717544.2012.738436

[49]

Modelli ME, Cherulli ÁS, Gandolfi L, et al. Atherosclerosis in young Brazilians suffering violent deaths: a pathological study[J]. BMC Res Notes, 2011, 4: 531. doi: 10.1186/1756-0500-4-531

[50]

Lawson JS, Glenn WK. Infection and food combine to cause atherosclerotic coronary heart disease - Review and hypothesis[J]. Int J Cardiol Heart Vasc, 2021, 35: 100807. https://www.sciencedirect.com/science/article/pii/S2352906721000956

[51]

Fatkhullina AR, Peshkova IO, Koltsova EK. The role of cytokines in the development of atherosclerosis[J]. Biochemistry (Moscow), 2016, 81(11): 1358-1370. doi: 10.1134/S0006297916110134

[52]

Chistiakov DA, Orekhov AN, Sobenin IA, et al. Plasmacytoid dendritic cells: development, functions, and role in atherosclerotic inflammation[J]. Front Physiol, 2014, 5: 279. doi: 10.3389/fphys.2014.00279/full

[53]

Sobenin IA, Sazonova MA, Postnov AY, et al. Mitochondrial mutations are associated with atherosclerotic lesions in the human aorta[J]. Clin Dev Immunol, 2012, 2012: 832464. https://www.hindawi.com/journals/jir/2012/832464/

[54]

Vekemans J, Hasso-Agopsowicz M, Kang G, et al. Leveraging vaccines to reduce antibiotic use and prevent antimicrobial resistance: a world health organization action framework[J]. Clin Infect Dis, 2021, 73(4): e1011-e1017. doi: 10.1093/cid/ciab062

[55]

Henein MY, Vancheri S, Longo G, et al. The role of inflammation in cardiovascular disease[J]. Int J Mol Sci, 2022, 23(21): 12906. doi: 10.3390/ijms232112906

[56]

Hruby A, Hu FB. The epidemiology of obesity: a big picture[J]. Pharmacoeconomics, 2015, 33(7): 673-689. doi: 10.1007/s40273-014-0243-x

[57]

Kwon EJ, Kim YJ. What is fetal programming?: a lifetime health is under the control of in utero health[J]. Obstet Gynecol Sci, 2017, 60(6): 506-519. doi: 10.5468/ogs.2017.60.6.506

[58]

Reynolds CM, Gray C, Li M, et al. Early life nutrition and energy balance disorders in offspring in later life[J]. Nutrients, 2015, 7(9): 8090-8111. doi: 10.3390/nu7095384

[59]

Ren L, Cai J, Liang J, et al. Impact of cardiovascular risk factors on carotid intima-media thickness and degree of severity: a cross-sectional study[J]. PLoS One, 2015, 10(12): e0144182. doi: 10.1371/journal.pone.0144182

[60]

Lumey LH, Stein AD, Susser E. Prenatal famine and adult health[J]. Annu Rev Public Health, 2011, 32: 237-262. doi: 10.1146/annurev-publhealth-031210-101230

[61]

Bi Y, Lu J, Wang W, et al. Cohort profile: risk evaluation of cancers in Chinese diabetic individuals: a longitudinal (REACTION) study[J]. J Diabetes, 2014, 6(2): 147-157. doi: 10.1111/1753-0407.12108

[62]

Li J. Severe hypertension in China: results from the China PEACE million persons project[J]. J Hypertens, 2021, 39(3): 461-470. doi: 10.1097/HJH.0000000000002675

[63]

Richard AJ, White U, Elks CM, et al. Adipose tissue:physiology to metabolic dysfunction[M]//Feingold KR, Anawalt B, Blackman MR, et al. Endotext[Internet]. South Dartmouth: MDText. com, Inc., 2020.

[64]

Zorena K, Jachimowicz-Duda O, Ślęzak D, et al. Adipokines and obesity. Potential link to metabolic disorders and chronic complications[J]. Int J Mol Sci, 2020, 21(10): 3570. doi: 10.3390/ijms21103570

PDF (1881KB)

0

Accesses

0

Citation

Detail

Sections
Recommended

/